Name | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Symbol | ERBB2 |
Aliases | NEU; NGL; HER2; HER-2; Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) |
Gene Product | - v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog
|
Category | - Amplification in Prostate cancer
|
UniGene | Hs.323910 |
OMIM | 164870 |
Locus | 2064 |
Summary | Tyrosine kinase receptor, a component of IL-6 signalling through the MAP kinase pathway; similar to the EGF receptor |
Gene Ontology | |
Expression | EST (266 ESTs, 155 libraries) |
Tissue ? |
Frequency ? |
Count ? |
bone marrow (2/263) | | 2/38555 |
brain (5/204) | | 6/362011 |
colon (34/853) | | 63/165626 |
embryo (1/19) | | 4/37976 |
eye (4/33) | | 10/93836 |
head and neck (8/990) | | 12/79796 |
heart (1/22) | | 2/55494 |
intestine (1/4) | | 4/11528 |
kidney (3/86) | | 3/132968 |
lung (5/312) | | 9/245386 |
muscle (2/21) | | 7/71297 |
nervous (1/475) | | 1/43438 |
oral cavity (1/18) | | 2/44567 |
ovary (4/144) | | 7/81880 |
pancreas (4/33) | | 7/117255 |
placenta (14/342) | | 20/157762 |
prostate (5/291) | | 7/109871 |
skin (1/31) | | 1/100815 |
spleen (1/7) | | 1/9511 |
stomach (9/312) | | 13/129930 |
testis (1/171) | | 3/117531 |
uncharacterized tissue (41/1773) | | 73/713325 |
uterus (5/212) | | 7/155110 |
|
SAGE (8882218 tags, 180 libraries) |
Tissue ? |
Frequency ? |
Count ? |
brain (13/19) | | 27/1157884 |
cerebellum (1/1) | | 2/102560 |
colon (8/8) | | 24/837255 |
eye (5/6) | | 7/489513 |
heart (1/1) | | 3/253071 |
kidney (2/2) | | 4/73935 |
liver (1/1) | | 3/200583 |
lung (1/1) | | 4/178286 |
mammary gland (12/19) | | 108/1358570 |
muscle (2/2) | | 38/269309 |
ovary (6/10) | | 15/313345 |
pancreas (7/8) | | 26/478962 |
prostate (11/13) | | 47/958610 |
skin (4/7) | | 6/62013 |
stomach (2/3) | | 16/409395 |
uncharacterized tissue (17/22) | | 118/1610180 |
vascular (2/3) | | 2/128747 |
|
|
SNP | rs272159 (G/A:exception);  rs1058808 (C/G:exception);  rs2952154 (G/A:exception);  rs2904764 (G/A:locus-region);  rs2313170 (A/G:exception);  rs1565923 (A/G:exception);  rs445358 (A/G:exception);  rs2643193 (A/G:locus-region);  rs2517951 (T/C:locus-region);  rs2088126 (A/G:exception);  rs1801200 (G/A:exception);  rs387082 (T/N:exception);  rs169244 (G/A:exception);  rs1810132 (C/T:exception);  rs2172826 (C/G:exception);  rs2230700 (G/T:mrna-utr);  rs2934967 (G/T:locus-region);  rs903506 (A/G:exception);  rs2517959 (C/A:locus-region);   |
Evidence | Amplification in Prostate cancer
|